do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Can dipeptidyl peptidase‑4 (DPP‑4) be combined semaglutide ( GLP‑1 agonist)? GLP 1 Receptor Agonists and

The concern with these medications is that the delayed gastric emptying leads to residual gastric contents, which may increase the risk of aspiration

Alternative methods of contraception should be considered

[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Hernandez N.S., ODonovan B., Ortinski P.I., Schmidt H.D

Individuals taking Wegovy, particularly older adults, may be at a higher risk of developing NAION and should seek medical attention immediately for blurred vision, blindness, or other sight concerns

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 269,00 per year only 22,42 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

This journey with GLP-1s has been eye-opening for me, not just for the physical changes, but for the deeper understanding of how interconnected our brains and bodies areand how that knowledge could lead to breakthroughs in addiction treatment